Trazodone
- PMID: 29262060
- Bookshelf ID: NBK470560
Trazodone
Excerpt
Trazodone is a medication used in the management and treatment of major depressive disorder. This drug is in the serotonin-antagonist-and-reuptake-inhibitor class of medications; it can be used as a component of combination therapy with other drugs or psychotherapies or as monotherapy for treating depression. Trazodone is an antidepressant that inhibits serotonin transporter and serotonin type 2 receptors; it is a triazolopyridine derivative. Trazodone inhibits the reuptake of serotonin and blocks the histamine and α-1-adrenergic receptors. This activity reviews the indications, actions, and contraindications for trazodone as a valuable agent in managing major depression. This activity will highlight the mechanism of actions, adverse effects, and other key factors (eg, off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, and relevant interactions) pertinent to interprofessional team members in treating patients with depression and related conditions.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Schwasinger-Schmidt TE, Macaluso M. Other Antidepressants. Handb Exp Pharmacol. 2019;250:325-355. - PubMed
-
- McQuaid JR, Buelt A, Capaldi V, Fuller M, Issa F, Lang AE, Hoge C, Oslin DW, Sall J, Wiechers IR, Williams S. The Management of Major Depressive Disorder: Synopsis of the 2022 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Ann Intern Med. 2022 Oct;175(10):1440-1451. - PubMed
-
- Khouzam HR. A review of trazodone use in psychiatric and medical conditions. Postgrad Med. 2017 Jan;129(1):140-148. - PubMed
Publication types
LinkOut - more resources
Full Text Sources